Abiopharma

🔍 Ridolfi Robert N. (Executive)

Company: Princeton Bancorp, Inc. (BPRN)

Report Date: 2026-06-12

Detailed Transactions and Holdings:

• Acquired 355 shares of Phantom stock (Derivative)
  Date: 2026-06-12 | Code: I | equity_swap_involved: false | shares_owned_after: 9,502.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Acquired 46 shares of Phantom stock (Derivative)
  Date: 2026-06-15 | Code: I | equity_swap_involved: false | shares_owned_after: 9,548.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Acquired 663 shares of Phantom stock (Derivative)
  Date: 2026-06-16 | Code: I | equity_swap_involved: false | shares_owned_after: 10,211.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: Acquired under the issuer's Non-Employee Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of BPRN common stock. The shares of phantom stock become payable, in cash or common stock, at the election of the reporting person, upon the reporting person's termination of service as a director.